Chromatin Protein PC4 Orchestrates B Cell Differentiation by Collaborating with IKAROS and IRF4

被引:19
|
作者
Ochiai, Kyoko [1 ]
Yamaoka, Mari [1 ]
Swaminathan, Amrutha [2 ]
Shima, Hiroki [1 ]
Hiura, Hitoshi [3 ,11 ]
Matsumoto, Mitsuyo [1 ,4 ]
Kurotaki, Daisuke [5 ]
Nakabayashi, Jun [6 ]
Funayama, Ryo [4 ,7 ]
Nakayama, Keiko [4 ,7 ]
Arima, Takahiro [3 ]
Ikawa, Tomokatsu [8 ]
Tamura, Tomohiko [5 ,6 ]
Sciammas, Roger [9 ]
Bouvet, Philippe [10 ]
Kundu, Tapas K. [2 ]
Igarashi, Kazuhiko [1 ,4 ]
机构
[1] Tohoku Univ, Dept Biochem, Grad Sch Med, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan
[2] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Bangalore 560064, Karnataka, India
[3] Tohoku Univ, Environm & Genome Res Ctr, Dept Informat Genet, Grad Sch Med, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan
[4] Tohoku Univ, Ctr Regulatory Epigenome & Dis, Grad Sch Med, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan
[5] Yokohama City Univ, Dept Immunol, Grad Sch Med, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan
[6] Yokohama City Univ, Adv Med Res Ctr, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan
[7] Tohoku Univ, United Ctr Adv Res & Translat Med, Div Cell Proliferat, Grad Sch Med, Seiryo Machi 2-1, Sendai, Miyagi 9808575, Japan
[8] Tokyo Univ Sci, Div Immunobiol, Yamazaki 2669, Noda, Chiba 2780022, Japan
[9] Univ Calif Davis, Ctr Immunol & Infect Dis, Davis, CA 95616 USA
[10] Univ Lyon, Ctr Rech Cancerol Lyon, Ctr Leon Berard, Canc Cell Plast Dept,UMR INSERM 1052,CNRS 5286,Ec, Lyon, France
[11] Tokyo Univ Agr, Dept Biosci, Sakuragaoka 1-1-1, Tokyo 1568502, Japan
来源
CELL REPORTS | 2020年 / 33卷 / 12期
基金
日本学术振兴会;
关键词
TRANSCRIPTIONAL COACTIVATOR PC4; CLASS SWITCH RECOMBINATION; NUCLEAR LAMINA; PRE-B; REGULATORY NETWORK; GENE CONVERSION; FACTOR BLIMP-1; MATURE B; EXPRESSION; HETEROCHROMATIN;
D O I
10.1016/j.celrep.2020.108517
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The chromatin protein positive coactivator 4 (PC4) has multiple functions, including chromatin compaction. However, its role in immune cells is largely unknown. We show that PC4 orchestrates chromatin structure and gene expression in mature B cells. B-cell-specific PC4-deficient mice show impaired production of antibody upon antigen stimulation. The PC4 complex purified from B cells contains the transcription factors (TFs) IKAROS and IRF4. IKAROS protein is reduced in PC4-deficient mature B cells, resulting in de-repression of their target genes in part by diminished interactions with gene-silencing components. Upon activation, the amount of IRF4 protein is not increased in PC4-deficient B cells, resulting in reduction of plasma cells, Importantly, IRF4 reciprocally induces PC4 expression via a super-enhancer. PC4 knockdown in human B cell lymphoma and myeloma cells reduces IKAROS protein as an anticancer drug, lenalidomide. Our findings establish PC4 as a chromatin regulator of B cells and a possible therapeutic target adjoining IKAROS in B cell malignancies.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] IRF8 and IRF4 may work cooperatively in CD8T cell effector differentiation
    Miyagawa, F.
    Zhang, H.
    Katz, S. I.
    Asada, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S9 - S9
  • [42] Tet DNA demethylase is required for plasma cell differentiation by controlling expression levels of IRF4
    Fujii, Kentaro
    Tanaka, Shinya
    Hasegawa, Takanori
    Narazaki, Masashi
    Kumanogoh, Atsushi
    Koseki, Haruhiko
    Kurosaki, Tomohiro
    Ise, Wataru
    INTERNATIONAL IMMUNOLOGY, 2020, 32 (10) : 683 - 690
  • [43] Clinical boundaries in adult cases of large B cell lymphoma with IRF4 rearrangement
    Maguire, Jessica
    Harvey, Harry
    Jones, Alfred
    Law, Ruth
    Bashir, Masoud
    O'Brien, Odharnaith
    Sargent, Jeremy
    Grant, Cliona
    Flavin, Richard
    HISTOPATHOLOGY, 2024, 84 (02) : 399 - 401
  • [44] Gastrointestinal large B-cell lymphoma with IRF4 rearrangement - a case report
    Hurdogan, O.
    Yegen, G.
    Arslantas, E.
    Gulluoglu, M.
    Dogan, I. O.
    VIRCHOWS ARCHIV, 2018, 473 : S273 - S274
  • [45] Large B-Cell Lymphoma With IRF4 Rearrangement: From Theory to Practice
    Vincent, Gabriel
    Richebourg, Steven
    Cloutier, Stephanie
    Fortin, Melanie
    Jacob, Simon
    Amin-Hashem, Mohamed
    AJSP-REVIEWS AND REPORTS, 2019, 24 (05): : 240 - 243
  • [46] Case Report of Refractory Large B-Cell Lymphoma With IRF4 Rearrangement
    Sevgili, Bahar
    Abdullayeva, Nigar
    Kir, Selin
    Demir, Derya
    Hekimgil, Mine
    Yavasoglu, Irfan
    Sahin, Fahri
    Saydam, Guray
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S466 - S466
  • [47] Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function
    Nam, Sorim
    Kang, Kyeongah
    Cha, Jae Seon
    Kim, Jung Woo
    Lee, Hee Gu
    Kim, Yonghwan
    Yang, Young
    Lee, Myeong-Sok
    Lim, Jong-Seok
    JOURNAL OF LEUKOCYTE BIOLOGY, 2016, 100 (06) : 1273 - 1284
  • [48] IRF4 transcriptionally activate HOTAIRM1, which in turn regulates IRF4 expression, thereby affecting Th9 cell differentiation and involved in allergic rhinitis
    Li, Lihua
    Deng, Jianjian
    Huang, Taojian
    Liu, Ke
    Jiang, Xunshuo
    Chen, Xubo
    Yang, Chunping
    GENE, 2022, 813
  • [49] IRF4 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasms
    van Slambrouck, C. M.
    Hyjek, E.
    Gurbuxani, S.
    LABORATORY INVESTIGATION, 2013, 93 : 364A - 365A
  • [50] IRF4 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasms
    van Slambrouck, C. M.
    Hyjek, E.
    Gurbuxani, S.
    MODERN PATHOLOGY, 2013, 26 : 364A - 365A